🔎 Trials Near Me

Utama › Kanser Prostat › Delaware › Newark

Kajian klinikal Kanser Prostat di Newark, DE

10 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Newark (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Mengambil pesertaFasa 1/2
  • Medical Oncology Hematology Consultants, Newark
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Mengambil pesertaFasa 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Mengambil pesertaFasa 2
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06632977

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Mengambil pesertaFasa 3
  • Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark
Umur 18 ke atas · Lelaki · Dikemas kini 22 Sep 2026 · NCT07213674

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Mengambil pesertaFasa 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Umur 18 ke atas · Lelaki · Dikemas kini 10 Sep 2026 · NCT05946213

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Mengambil pesertaFasa 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
  • dan 1 lagi
Umur 18 ke atas · Lelaki · Dikemas kini 14 Jul 2026 · NCT06592924

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Mengambil pesertaFasa 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
  • dan 1 lagi
Umur 18 ke atas · Lelaki · Dikemas kini 22 Jan 2026 · NCT06470243

Vitamin D for Prostate Endocrine Therapy

Mengambil pesertaFasa 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Umur 50 ke atas · Lelaki · Dikemas kini 15 Jan 2026 · NCT05838716

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Newark
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Mengambil pesertaFasa 3
  • Helen F Graham Cancer Center, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
Umur 18 ke atas · Lelaki · Dikemas kini 11 Sep 2025 · NCT03678025

Kajian Kanser Prostat di bandar lain

Kajian lain di Newark

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.